Loss of <i>BAP1</i> expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy developmentCarlos R. Figueiredo, Sarah E. Coupland|The Journal of Pathology|2020Cited by 157
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivoCarlos R. Figueiredo, Luiz R. Travassos|Scientific Reports|2015Cited by 23
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicityMiriam Langguth, Carlos R. Figueiredo|Genes and Immunity|2024Cited by 16
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunitiesMaisoon Matareed, Carlos R. Figueiredo|The Journal of Pathology|2023Cited by 10
Novel CRISPR-Cas9 BAP1 Knockout Pre-Clinical Tumor Model Recapitulates Human Melanoma Tumorigenesis and Immune EvolutionMona Wang, Carlos R. Figueiredo|Research Square|2025Cited by 0